Navigation Links
Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook

en) from 2000 to 2002. He served as a senior associate with PricewaterhouseCoopers from 1997 to 2000. Dr. Viret holds an M.B.A. from the Johnson School at Cornell University, and a Ph.D. in molecular biology from the Universite Louis Pasteur. He completed a postdoctoral fellowship in molecular biology at the Massachusetts Institute of Technology and was a visiting fellow in molecular biology at Harvard University. Dr. Viret is also a certified public accountant.

Additional developments include:

-- Appointed Daniel S. Janney, a managing director of Alta Partners, a

venture capital firm investing in life sciences and information

technology companies, to the Anesiva board of directors.

- Completed successful public offering of common stock in December,

raising net proceeds of approximately $47.7 million.

Fourth Quarter and Fiscal Year 2007 Financial Results

Total operating expenses in the fourth quarter of 2007 were $18.1 million, including $1.7 million of non-cash stock-based compensation, compared to total operating expenses of $16.2 million, including $2.3 million of non-cash stock-based compensation, in the fourth quarter of 2006. For the year ended December 31, 2007, operating expenses were $61.5 million compared to $58.8 million for the year ended December 31, 2006.

Operating expenses during the quarter primarily related to the continued development and commercial preparations to launch the company's lead product candidate, Zingo, a fast-acting, needle-free, local anesthetic. Additional operating expenses related to the ongoing development of Adlea, which has been shown in numerous clinical studies to provide site-specific, moderate-to-severe pain relief for weeks to months following a single application.

For the fourth quarter of 2007, Anesiva's net loss was $17.7 million, or $0.60 per share. In the fourth quarter of 2006, the net loss was $15.3 million, or $0.65 per share. The ne

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Anesiva Appoints Daniel Janney to Board of Directors
2. Anesiva Announces Fourth Quarter and Year End 2007 Financial Results Conference Call and February 2008 Conference Participation
3. Anesiva Announces Completion of Common Stock Offering
4. Anesiva Raises $45 Million in Common Stock Offering
5. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
6. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
7. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
8. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
9. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
Post Your Comments:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... , , , , , , , ... , , 1691112, 100 g, ... Package Inserts/Product , Instructions , , German , ... version - 54 K , , US Material Safety , ...
... , , , Catalog Number, ... 1691104, Set, , , , ... , English , version - 24 K , ... US Material Safety , Data Sheets , , ...
... Here are some troubleshooting hints that we have gathered , regarding misincorporation or low fidelity of PCR reactions: , , ... , , , ... , <a , ... , , <a , ...
Cached Biology Technology:Trouble-shooting: Misincorporation or low fidelity 2Trouble-shooting: Misincorporation or low fidelity 3
(Date:4/15/2014)... University of Missouri researchers have previously shown that ... to exercise exists. In a new study, Frank Booth, ... has found a potential link between the genetic pre-disposition ... at which mental maturation occurs. , For his study, ... extreme activity or extreme laziness. Booth then put the ...
(Date:4/15/2014)... The global experts who study the deadliest infectious ... Thomas G. Ksiazek, professors at the University of Texas ... 6th annual International Symposium on Filoviruses. The filoviruses include ... to 90 percent of people infected. The current outbreak ... more than 100 deaths so far. , "This ...
(Date:4/15/2014)... pastoral landscapes are some of the loveliest in the ... of the country,s pasture soils have become enriched in ... is then eaten by the cattle and sheep that ... Zealand; cadmium-enriched soils being reported worldwide. , The concern ... in meat and dairy products, human health and New ...
Breaking Biology News(10 mins):Genetic pre-disposition toward exercise and mental development may be linked 2International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3
... Alzheimer,s is set to take a step forward following ... automated 3D microscopy. An initiative between the ... Institute for Cellular and Molecular Biology, the technology will ... as complex as nerve cells in the brain. ...
... is available in French . Vancouver, B.C. -- ... place at the wrong time. As a result of changing conditions, marine ... as three kilometres per year over the past 50 years, and forecasts ... years. Decisions on where to put MPAs weren,t always made with ...
... years, biologists have been amazed by the power of gecko ... roughly equivalent to carrying nine pounds up a wall without ... at the University of Massachusetts Amherst have discovered exactly how ... device that can hold 700 pounds on a smooth wall. ...
Cached Biology News:Marine protected areas: changing climate could require change of plans 2Inspired by gecko feet, UMass Amherst scientists invent super-adhesive material 2
... Combining linear motor and ballscrew ... pre-engineered Cartesian solutions that include ... management, and motors., , ... Pass through high-flex cabling for ...
UGT1A6 (D-20)...
... T Squareds patented high efficiency dynamic valve ... With the most compact, lightweight package in ... use in portable air and gas applications., ... high efficiency. , Includes DC Motor. ...
... designed for moving loads quickly and accurately. ... output while limiting overall size. The P5S-P ... ball bearings guided on two rails., ... provide energy absorption and controlled deceleration , ...
Biology Products: